Novartis Investigative Site

Athens, Greece GR 156 69

0 studies enrolling now · 6 studies all time

What they study most

Behcet Disease, Carcinoid Tumor, Cardiovascular Disease, Chronic Heart Failure, HER2/Neu Over-expressing Locally Advanced Breast Cancer, Malignant Carcinoid Syndrome, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma, Type 2 Diabetes Mellitus

Studies at this site

• Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma — Completed
• Phase III Study in Refractory Behcet's Disease — Completed
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early